OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31

OMEROS CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$16.35+0.15 (+0.93%)

Close on Oct 19, 2026

Market cap: $1.47B
P/E (TTM): –
Dividend yield: –

OMEROS CORP balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30	Q2 2016 2016-06-30
Cash & Equivalents	1.99	1.91	9.66	2.40	1.90	4.26	3.40	1.52	2.12	1.83	7.11	31	6.60	3.83	11	146	14	8.96	101	7.42	9.03	11	21	1.96	7.12	3.08	8.86	3.99	4.05	5.86	2.79	2.88	1.19	3.39	1.03	3.39	1.28	2.22	10	4.59
Short-Term Investments	130	133	162	34	27	48	87	122	157	229	165	280	335	368	184	75	108	133	56	43	91	124	132	14	47	58	18	28	–	55	–	–	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	132	135	172	36	29	52	90	123	159	230	172	310	341	371	195	221	123	142	157	50	100	135	154	16	54	61	27	32	4.05	61	55	88	73	84	87	30	34	45	47	21
Receivables	12	6.75	0	6.91	6.28	7.08	7.74	6.39	8.08	7.64	8.10	6.88	11	10	213	14	14	16	38	34	25	3.84	37	16	24	35	30	29	25	23	2.30	1.53	0.18	17	25	19	13	12	10	8.81
Inventory	0.84	0.18	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.71	1.19	1.36	1.54	1.89	1.21	1.15	1.17	1.19	0.74	0.09	0.21	0.24	0.25	0.44	0.82	0.91	0.96	1.13	1.40	1.78
Prepaid Expenses & Other	5.54	7.35	7.60	3.76	6.41	7.47	7.17	6.13	6.27	13	8.58	4.92	7.00	6.71	6.30	5.98	12	7.62	8.22	6.37	5.98	10	3.54	5.17	6.30	6.63	5.35	4.40	–	6.46	8.33	6.34	5.44	7.04	5.69	3.45	3.26	1.77	1.36	2.28
Total Current Assets	185	180	216	72	70	96	134	165	203	281	218	351	389	417	443	289	193	210	248	91	132	151	196	39	86	104	64	66	77	90	66	97	79	108	118	53	51	60	61	34
Property, Plant & Equipment	1.38	1.53	1.77	2.01	2.24	2.42	2.68	1.94	2.03	1.80	1.95	1.72	1.75	1.34	1.49	1.85	1.92	1.45	1.73	1.83	2.17	2.55	2.95	3.11	3.36	3.83	3.79	4.18	4.48	3.85	2.52	2.44	2.08	2.12	1.79	1.43	1.22	1.18	1.21	1.25
Gross Property, Plant & Equipment	14	14	14	14	14	14	14	13	13	12	12	12	–	–	11	–	–	–	–	–	–	10	10	9.96	9.79	9.86	9.29	9.26	9.10	8.09	–	–	–	5.40	–	–	–	3.91	–	–
Accumulated Depreciation	-12	-12	-12	-12	-12	-11	-11	-11	-11	-10	-10	-10	–	–	-9.55	–	–	–	–	–	–	–	-7.25	-6.85	-6.44	-6.04	-5.51	-5.07	-4.62	-4.25	–	–	–	-3.28	–	–	–	-2.73	–	–
Operating Lease Right-of-Use Assets	8.28	9.52	11	12	13	14	15	16	17	18	19	19	20	21	22	22	23	23	28	29	25	26	26	27	27	27	21	17	18	0	–	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0.07	0.07
Total Assets	287	286	326	186	201	235	277	313	356	437	378	493	527	560	591	458	346	369	419	123	161	181	227	71	118	137	91	90	101	96	76	106	89	116	126	60	58	67	73	46
Accounts Payable	6.34	5.37	4.76	12	8.84	4.41	5.91	7.72	6.50	6.18	7.71	5.87	9.55	6.45	5.99	17	11	7.35	13	10	11	4.20	7.02	8.51	13	5.33	9.70	6.26	7.12	6.28	8.85	12	10	6.69	3.68	2.57	2.41	2.52	3.99	5.42
Accrued Expenses	29	28	29	26	26	25	26	23	28	28	32	35	30	31	31	18	23	24	33	28	28	29	37	26	41	47	34	32	35	30	15	12	14	19	20	22	14	13	12	10
Current Portion of Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.56	0.89	0.56	0.61	0.51	0.49	0.37	0.25	0.23	0.20	0.19	0.19
Current Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.56	0.89	0.56	0.61	0.51	0.49	0.37	0.25	0.23	0.20	0.19	0.19
Current Portion of Leases	–	–	5.80	–	–	–	5.24	–	–	–	4.59	–	–	–	3.89	–	–	–	4.61	–	–	2.74	2.62	2.50	2.39	2.28	1.93	1.49	1.42	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	0.66	1.15	1.15	–	–	–	0.06	0.81	1.54	1.18	0.32	1.23	1.23	4.87	5.54	–	–	–	0.34	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	5.00	2.82	2.47	–	–	–	0.18	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	95	59	78	81	86	83	80	56	59	59	53	147	144	139	136	40	39	35	52	43	43	37	48	38	58	55	47	41	45	37	25	24	25	26	25	25	17	16	16	16
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	132	130	85	84	83	82	81	80	70	70
Long-Term Leases	–	–	6.52	–	–	–	12	–	–	–	17	–	–	–	22	–	–	–	29	–	–	28	29	29	30	31	27	24	25	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	–	–	12	–	–	–	17	–	–	–	22	–	–	–	26	–	–	–	33	–	–	31	31	32	33	33	29	26	26	–	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	4.16	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	338	350	447	406	429	449	460	468	481	509	403	507	507	505	505	504	378	374	395	386	383	302	314	232	250	246	231	220	222	196	165	163	118	119	116	115	107	105	96	95
Total Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.56	0.89	132	130	86	85	83	82	81	80	70	70
Preferred Stock	0	0	0	0	0	0	0	0	0	0	0	0	–	–	0	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	0	0	0	0	–
Common Stock	0.72	0.72	0.72	0.70	0.60	0.58	0.58	0.58	0.58	0.58	0.61	0.63	0.63	0.63	0.63	0.63	0.63	0.63	0.63	0.63	0.62	0.62	0.62	0.55	0.55	0.54	0.50	0.49	0.49	0.49	0.49	0.49	0.48	0.48	0.48	0.44	0.44	0.44	0.43	0.39
Additional Paid-In Capital	792	794	792	779	740	730	727	724	722	719	728	730	727	724	721	718	714	711	706	700	690	751	747	635	631	625	565	558	553	549	537	530	524	520	516	444	436	432	427	387
Retained Earnings	-844	-858	-914	-1,000	-969	-944	-910	-879	-847	-791	-754	-744	-707	-669	-636	-764	-747	-716	-683	-964	-912	-873	-835	-797	-764	-735	-705	-689	-674	-650	-627	-587	-553	-523	-507	-499	-485	-470	-450	-436
Shareholders' Equity	-51	-63	-121	-220	-229	-214	-183	-154	-125	-71	-25	-14	21	55	86	-46	-33	-4.93	24	-263	-222	-121	-87	-161	-132	-109	-140	-130	-121	-100	-89	-56	-29	-2.81	9.21	-55	-48	-37	-23	-49
Total Equity	-51	-63	-121	-220	-229	-214	-183	-154	-125	-71	-25	-14	21	55	86	-46	-33	-4.93	24	-263	-222	-121	-87	-161	-132	-109	-140	-130	-121	-100	-89	-56	-29	-2.81	9.21	-55	-48	-37	-23	-49
Total Liabilities & Equity	287	286	326	186	201	235	277	313	356	437	378	493	527	560	591	458	346	369	419	123	161	181	227	71	118	137	91	90	101	96	76	106	89	116	126	60	58	67	73	46
Shares Outstanding(shares)	72	72	72	70	60	58	58	58	58	58	61	63	63	63	63	63	63	63	63	63	62	62	62	55	55	54	50	49	49	49	49	48	48	48	48	44	44	44	43	39

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 2.2%

Financial strength

Current ratio: 1.95
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 2.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –